USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
PATHENS, INC.
Address:
220 Riverbend Road
Athens, GA
Phone:
N/A
URL:
N/A
EIN:
176080070
DUNS:
602672813
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $600,000.00 1

Award List:

A novel live intranasal TB vaccine

Award Year / Program / Phase:
2012 / STTR / Phase I
Award Amount:
$600,000.00
Agency:
HHS
Principal Investigator:
Frederick D. Quinn – 706-542-5790
Research Institution:
UNIVERSITY OF GEORGIA (UGA)
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): The most-widely used vaccine for TB currently is BCG, a live avirulent variant of M. bovis that is given intradermally at birth. Along with the inherent safety and logistical problems associated with being injected, protective efficacy is generally poor and wanes… More